Whether you can comfortably drink milk as an adult comes down largely to a single DNA switch near the LCT gene. Persistent lactase activity is the evolutionary exception in humans, not the default.
Lactose is the main sugar in milk. To absorb it, the small intestine makes an enzyme called lactase, which splits lactose into two simpler sugars the body can take up. Every human infant makes plenty of lactase so they can digest their mother's milk. What varies enormously between people — and between populations — is what happens to that enzyme after weaning.
In most mammals, and in most humans worldwide, lactase production winds down once early childhood ends. This is called lactase non-persistence, and it is the ancestral, default pattern for the species. In some populations, though, a genetic change lets lactase production continue at high levels for life — a trait called lactase persistence. It is easy to assume persistence is "normal" simply because it is common in some Western countries, but from a species-wide and evolutionary standpoint, it is the unusual trait that needs explaining, not the other way around.
When someone with low lactase activity consumes more lactose than their gut can break down, the undigested sugar travels into the colon, where it draws in water and is fermented by resident bacteria. This produces gas and short-chain fatty acids, leading to the classic symptoms of lactose intolerance:
Symptoms usually start 30 minutes to two hours after eating or drinking dairy and are dose-dependent — many people with reduced lactase can tolerate small amounts of milk, hard cheese, or yogurt (which contains bacteria that pre-digest some lactose) without trouble, even though a large glass of milk causes problems.
Lactase persistence became common only in the last several thousand years, in populations with a long history of dairy farming, most prominently in Northern Europe and in some pastoralist groups in Africa and the Middle East. Because dairying created a strong survival advantage for people who could keep drinking milk into adulthood, the genetic variants that keep the lactase gene switched on spread rapidly through those populations — a textbook example of recent, diet-driven human evolution.
In populations without this history of dairy pastoralism — including much of East Asia, and many Indigenous populations of the Americas and Australia — lactase non-persistence remains the norm in the large majority of adults. Reduced lactose digestion after infancy is estimated to affect around two-thirds of people worldwide, though the true figure in any given population depends heavily on ancestry, ranging from about 5% of adults in some Northern European countries to well over two-thirds, and in some East Asian populations close to all adults.
Lactose intolerance is a digestive issue caused by an enzyme shortfall, not an immune reaction — it is distinct from a milk protein allergy, which involves the immune system and can be more dangerous. It is also distinct from a much rarer, separate condition called congenital lactase deficiency, in which infants are born essentially unable to make functional lactase at all and develop severe watery diarrhea from their very first lactose-containing feed. Congenital lactase deficiency is caused by different, rarer changes within the lactase gene itself, is inherited in an autosomal recessive pattern, and is most common in Finland.
Most people work out their own lactose tolerance through trial and elimination — noticing that dairy triggers symptoms and that cutting back helps. Clinically, lactose intolerance can be confirmed with a hydrogen breath test (which detects the gas produced when gut bacteria ferment undigested lactose), a lactose tolerance blood test, or, increasingly, a genetic test for the common lactase-persistence variant. It is worth noting that lactase activity can also drop temporarily — "secondary" lactose intolerance — after a bout of gastroenteritis or with conditions that damage the gut lining, such as celiac disease; this form often improves once the underlying gut problem resolves.
Locus and variant. The lactase gene, LCT (OMIM *603202), sits on chromosome 2q21 and encodes lactase-phlorizin hydrolase, the brush-border enzyme that hydrolyzes lactose. Persistence of its expression into adulthood is controlled not by LCT itself but by a regulatory element roughly 14 kb upstream, within intron 13 of the neighboring MCM6 gene (OMIM *601806). The best-characterized variant there is rs4988235, historically written as -13910C>T, first reported by Enattah and colleagues (Nat Genet, 2002; PMID 11788828). The T allele acts as an enhancer that sustains LCT promoter activity into adulthood (persistence); the ancestral C allele allows the normal postnatal decline (non-persistence). Persistence is inherited as an autosomal dominant trait relative to non-persistence — one copy of a persistence allele is generally sufficient to maintain substantial lactase expression, so C/T heterozygotes are typically persisters, and C/C homozygotes are non-persisters.
Convergent evolution across populations. The -13910C>T variant explains the large majority of persistence in people of European ancestry, but it is nearly absent in sub-Saharan Africa, where several other, independently arisen regulatory variants in the same MCM6 region (including -14010G>C, -13907C>G, and -13915T>G) achieve the same functional outcome in different pastoralist populations. This is one of the clearer documented examples of convergent evolution at a single regulatory locus in humans, reflecting parallel selective pressure from dairy pastoralism arising independently in different regions within roughly the last 5,000–10,000 years.
Population frequency. Allele frequency for the persistence-associated T allele at rs4988235 shows a strong geographic gradient across Europe, generally highest in the north and lowest in the south and east; reported frequencies for the T allele across European cohorts commonly fall in the 55-75% range, with the highest values (upper 60s to mid 70s) in Scandinavia and Britain, whereas non-persistence-associated alleles predominate through much of Asia, and non-European persistence alleles predominate in some pastoralist African and Middle Eastern groups. Correspondingly, clinical lactase non-persistence (the phenotype) has been estimated at about 5% of adults in some Northern European countries versus a large majority of adults through much of East Asia. These are population frequencies, not individual predictions — genotype at a single regulatory SNP does not capture the rarer non-European persistence alleles, so a genetic test reporting only rs4988235 can misclassify persistence status in people of non-European ancestry.
Differential diagnosis. Primary (adult-type) lactase non-persistence should be distinguished from: congenital lactase deficiency (OMIM #223000), caused by rare structural loss-of-function variants within the LCT coding sequence itself, autosomal recessive, presenting with severe neonatal diarrhea and enriched in the Finnish population; secondary lactase deficiency, an acquired and often reversible reduction in brush-border lactase from mucosal injury (viral gastroenteritis, celiac disease, Crohn disease, chemotherapy); and other causes of the same symptom pattern such as irritable bowel syndrome, small intestinal bacterial overgrowth, and fructose malabsorption, which can mimic or coexist with lactose intolerance.
Diagnostic thresholds. The hydrogen breath test is considered positive when breath hydrogen rises by roughly ≥20 ppm over baseline after an oral lactose load (commonly 25–50 g), often accompanied by symptom reproduction. Genetic testing for rs4988235 (and regionally relevant alternative variants) indicates persistence/non-persistence genotype but does not measure current enzymatic function or symptom severity.
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about Lactose Intolerance (Lactase Persistence) comes down to these specific, well-studied positions — not a diagnosis.
No. Lactose intolerance is a digestive issue caused by low levels of the lactase enzyme, not an immune reaction. A milk protein allergy involves the immune system, can cause more severe or dangerous reactions, and is a separate condition entirely.
Because it's framed relative to a dairy-heavy diet that only became common with farming. Biologically, losing lactase production after weaning is the ancestral, default pattern for humans and most other mammals. Lifelong lactase persistence is the newer, derived trait that spread in populations with a long history of dairy farming.
Yes. Illness or gut damage — a stomach virus, celiac disease, Crohn disease — can temporarily or sometimes permanently reduce lactase activity regardless of genotype. This "secondary" lactose intolerance often improves once the underlying gut problem is treated.
Not necessarily. Most consumer and clinical genetic tests look at one variant, rs4988235, which explains most persistence in people of European ancestry. Some African and Middle Eastern populations carry different persistence variants at the same regulatory region, so testing only rs4988235 can give a misleading result in people from those backgrounds.
Many can tolerate small amounts, especially hard cheeses (which contain very little lactose) and yogurt (whose bacterial cultures pre-digest some lactose). Tolerance is generally dose-dependent, so a splash of milk in coffee affects people very differently than a full glass.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.